ArticleChemical science2023
Chalcogen-doped, (
Article in Chemical science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- π-Aggregation-free, fused perylene pentamers: synthesis, narrowband far-red to near-infrared emission, and chiroptical properties.Chemical science · 2026Article
- Light-Induced SO Extrusion from Tribenzothiepine S-oxides: A Precursor Approach to the Triphenylene Core.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025Article
- Precise Internal Postsynthetic Oxygen-Doping of Metallonanographenes.Precision chemistry · 2025Article
- Nanographene horizons: the emerging role of hexa-RSC advances · 2025Review
- Precisely metal doped nanographenes via a carbaporphyrin approach.Nature communications · 2025Article
- Multi-heteroatom doped nanographenes: enhancing photosensitization capacity by forming an electron donor-acceptor architecture.Chemical science · 2024Article
- Synthesis of π-conjugated polycyclic compounds by late-stage extrusion of chalcogen fragments.Beilstein journal of organic chemistry · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A series of chalcogen-doped nanographenes (NGs) and their oxides are described. Their molecular design is conceptually based on the insertion of different chalcogens into the hexa-
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.